Document is current
Any future updates will be listed below
-
Authors
Grassi, Francesca
Singh, Madhurendra https://orcid.org/0000-0001-9935-5706
Moussaud, Simon https://orcid.org/0000-0002-6340-9511
Rodriguez, Gabriela Vazquez https://orcid.org/0000-0001-9310-2433
Ali, Zaheer
Janssen, Kirsten https://orcid.org/0000-0003-3728-8530
Cheray, Mathilde https://orcid.org/0000-0002-7551-6357
Leonard, Elory
Andersson, Martin https://orcid.org/0009-0001-5999-5482
de Milito, Angelo https://orcid.org/0000-0003-2591-2914
Qian, Hong https://orcid.org/0000-0002-2512-9199
Walfridsson, Julian
Höglund, Andreas https://orcid.org/0009-0003-1308-6544
-
Funding
Funding for this research was provided by:
Stiftelsen för Strategisk Forskning (ID21-0048, ID21-0048, ID21-0048)
- License Information
-
More Information
Article History
Received: 20 December 2024
Revised: 13 May 2025
Accepted: 29 May 2025
First Online: 26 June 2025
Competing interests
: AH, FG, MS, SM, MC, MA, and ADM, are employees of Sprint Bioscience AB. AH, MA, and ADM, are shareholders in Sprint Bioscience AB. JW, is the founder of NeoTargets AB. GVR and ZA are employees of BioReperia AB. EL, and HQ, declare no conflict of interest.
